Poly Medicure Limited · NSE:POLYMED
Poly Medicure — Q2 FY2024-25 Earnings Presentation
10 slides from Poly Medicure's earnings presentation, September 2024
Slide 1: Financial Results Q2 (F.Y. 2024-25)
Financial Results Q2 (F.Y. 2024-25) Standalone & Consolidated Poly Medicure Ltd. September 2024 Confidential I Slide 1
Slide 2: Forward Looking Statement
Forward Looking Statement Disclaimer This presentation has been prepared for general information purposes in respect of Poly Medicure Limited (“Company”) together with any subsidiary, associate or joint venture, as applicable (together, with the Company, the “Group”) only, without regard to any spec
Slide 3: Our Strength: Consistent all-round growth
Our Strength: Consistent all-round growth ₹ ₹ ₹ REVENUE (₹ Crs) EBIDTA (₹ Crs) PBT (₹ Crs) PAT (₹ Crs) 1600.00 500.00 1375.79 400.00 300.00 1400.00 419.50 344.27 258.26 350.00 1200.00 1115.23 400.00 250.00 300.00 1000.00 923.06 303.50 237.49 200.00 179.28 804.79 300.00 263.45 250.00 216.44 161.49 25
Slide 4: Financial Performance Comparison
Financial Performance Comparison (Standalone & Consolidated) (₹ in lacs except per share data) Standalone Consolidated Quarter Ended Quarter Ended 30.09.2024 30.06.2024 30.09.2023 30.09.2024 30.06.2024 30.09.2023 (Unaudited) (Audited) (Unaudited) (Unaudited) (Audited) (Unaudited) Total income from 4
Slide 5: Ratio’s
Ratio’s ROCE ROCE 25.00% 25.00% 22.92%* 20.94% 20.00% 19.54%* 20.00% 17.48% 17.26% 15.00% 14.05% 14.51% 15.00% 13.56% 10.00% 10.00% 5.00% 5.00% 0.00% 0.00% % FY 2022 FY 2023 FY 2024 H12024-25 FY 2022 FY 2023 % FY 2024 H1 24-25 * Without QIP
Slide 6: Sales Performance
SALES PERFORMANCE Domestic/Export 120.00% 100.00% 31.36% 31.85% 29.26% 80.00% 60.00% 40.00% 68.64% 68.15% 70.74% 20.00% 0.00% FY 23-24 H1 23-24 H1 24-25 Export Domestic Sales FY 23-24 % H1 23-24 % H1 24-25 % Growth H1 over H1 Export 897.3 68.64% 426.30 68.15% 544.69 70.74% 27.77% Domestic 409.95 31.
Slide 7: Qualified Institutional Placement (QIP)
Qualified Institutional Placement (QIP) Institutional Demand ₹ 8,665 crs Allotment Total Fund Raise At Rs.1880/ share 1,000 crs (in INR) 60 new investors onboard (22.08.24) No. of meetings/ Roadshows 75 Confidential I Slide 7
Slide 8: QIP New Stakeholders
QIP New Stakeholders Shareholding - Adding Institutional Shareholders 70.00 66.03 62.56 60.00 50.00 40.00 30.00 23.58 19.26 20.00 14.71 13.86 10.00 0.00 Promoters Institutional Investors Indian public Pre QIP Post QIP 22.08.2024 Shareholder Category in % Pre QIP Post QIP 22nd August Promoters 66.03
Slide 9: Expansion
Expansion An outlay of ₹500 crs over next 2 years for 3 manufacturing facilities at Haryana, Uttarakhand and Rajasthan Exploring Technology Acquisition in the area of Cardiology, Renal and Critical Care Confidential I Slide 9
Slide 10: Thank You
Poly Medicure Limited Registered Office: Thank You 232 B, 3rd Floor, Okhla Industrial Estate, Phase III, New Delhi-110020, India Tel:- 91-11-33550700, 47317000, 26321838/99 For any general queries, Reach us at: info@polymedicure.com Visit: www.polymedicure.com Confidential I Slide 10